Dhanvantri Jeevan Rekha Ltd. has notified the stock exchange of an upcoming Board of Directors meeting, scheduled in compliance with regulatory disclosure requirements. The meeting is set for Thursday, May 28, 2026, at 01:00 PM, as communicated through a formal intimation dated May 19, 2026, from the company's registered office in Meerut, Uttar Pradesh.

Board Meeting Details

The intimation was filed pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The key details of the scheduled meeting are outlined below:

Agenda: Audited Financial Statements for Q4 FY26

The primary agenda of the board meeting is to consider and adopt the audited financial statements for the quarter and year ended March 31, 2026. This filing marks a key regulatory milestone for the company as it prepares to disclose its full-year financial performance to stakeholders and the exchange.

The intimation was signed by Ritika Bhandari, Company Secretary and Compliance Officer (M.No. A60961), on behalf of Dhanvantri Jeevan Rekha Ltd. The communication was addressed to the Listing Department of BSE Limited, P.J. Towers, Dalal Street, Fort, Mumbai.

Dhanvantri Jeevan Rekha Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The healthcare services company submitted the mandatory certificate for the quarter ended 31st March 2026.

Regulatory Compliance Filing

The certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Company Secretary Ritika Bhandari (ACS: A60961) filed the document with BSE Limited on 17th April 2026, addressing it to the exchange's management at P.J. Towers, Dalal Street, Fort, Mumbai.

Registrar Confirmation

M/s Beetal Financial & Computer Services (P) Ltd., serving as the company's registrar and share transfer agent, issued the compliance certificate dated 03rd April 2026. The SEBI-approved Category I registrar (SEBI Reg. No.: INR 000000262) confirmed adherence to dematerialization requirements during the quarter ended March 2026.

Beetal Financial confirmed that securities received from depository participants for dematerialization during the quarter were properly processed and confirmed to the depositories. The registrar also verified that security certificates received for dematerialization were mutilated and cancelled after due verification, with depositories' names substituted in the register of members within the prescribed 15-day timeline.

Company Background

Dhanvantri Jeevan Rekha Limited operates Dhanvantri Hospital, a healthcare facility located in Saket, Meerut, Uttar Pradesh. The company holds ISO 9001:2015 certification and maintains NABH pre-accreditation status. The hospital is incorporated under CIN No. L85110UP1993PLC015458 and operates with GSTIN No. 09AAACD5774B1ZS.

Regulatory Framework

The filing references multiple regulatory circulars including NSDL/CIR/II/5/2019 dated 25th January 2019, CDSL/OPS/RTA/POLCY/2019/14 dated 25th January 2019, and SEBI letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24th January 2019. These regulations ensure proper handling of securities dematerialization processes and maintain transparency in depository operations.

The quarterly certificate submission demonstrates the company's commitment to regulatory compliance and transparent corporate governance practices in the healthcare sector.